The warrior in the machine: Neuroscience goes to war

Nature Reviews Neuroscience

Volumn 15, Issue 12, 2014, Pages 825-834

  Tracey, Irene ^a   Flower, Rod ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANXIETY DISORDER; ARMY; ASPHYXIA; ATTENTION DEFICIT DISORDER; BIOLOGICAL WARFARE; BRAIN COMPUTER INTERFACE; BRAIN DEPTH STIMULATION; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; COOKING; DEPRESSION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; ELECTROENCEPHALOGRAM; ETHICS; HUMAN; MEDICAL SOCIETY; MENTAL STRESS; NANOTECHNOLOGY; NEUROFEEDBACK; NEUROSCIENCE; POSITIONAL ASPHYXIA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REHABILITATION; RESPIRATION DEPRESSION; REVIEW; SLEEP DISORDER; SLEEP QUALITY; SOLDIER; STONE AGE; SYNTHETIC BIOLOGY; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; UNCONSCIOUSNESS; WAR; CHEMICAL WARFARE; TRENDS;

BIOLOGICAL WARFARE; CHEMICAL WARFARE; HUMANS; MILITARY PERSONNEL; NEUROSCIENCES; WAR;

EID: 84922480317     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3835     Document Type: Review

References (152)

1. Brain Waves 1: Neuroscience, society and policy. The Royal Society [online], https://royalsociety.org/policy/projects/brain-waves/society-policy/(2011).
2. Brain Waves 2: Neuroscience: implications for education and lifelong learning. The Royal Society [online], https://royalsociety.org/policy/projects/brain-waves/education-lifelong-learning/(2011).
3. Brain Waves 3. Neuroscience, conflict and security. The Royal Society [online], http://royalsociety.org/policy/projects/brain-waves/conflict-security/(2012).
4. Brain Waves 4: Neuroscience and the law. The Royal Society [online], https://royalsociety.org/policy/projects/brain-waves/responsibility-law/(2011).
5. Novel neurotechnologies: intervening in the brain. Nuffield Council on Bioethics [online], http://nuffieldbioethics.org/wp-content/uploads/2013/06/Novel-neurotechnologies-report-PDF-web-0.pdf (2013).
6. Committee on Military and Intelligence Methodology for Emergent Neurophysiological and Cognitive/Neural Research in the Next Two Decades; National Research Council. Emerging Cognitive Neuroscience and Related Technologies [online], http://www.nap.edu/catalog. php?record-id=12177 (The National Academies Press, 2008).
7. Committee on Trends in Science and Technology Relevant to the Biological Weapons Convention: An International Workshop; National Research Council; in cooperation with Chinese Academy of Sciences, IAP-The Global Network of Science Academies; International Union of Biochemistry and Molecular Biology; International Union of Microbiological Sciences. Life Sciences and Related Fields: Trends Relevant to the Biological Weapons Convention [online], http://www.nap.edu/catalog.php?record-id=13130 (The National Academies Press, 2011).
8. Committee on Opportunities in Neuroscience for Future Army Applications; National Research Council. Opportunities in Neuroscience for Future Army Applications [online], http://www.nap.edu/catalog.php?record-id=12500 (The National Academies Press, 2009).
9. Moreno, J. D. Mind Wars: Brain Research and National Defense (Dana Press, 2006).
10. Tennison, M. N., Moreno, J. D. Neuroscience, ethics, and national security: the state of the art. PLoS Biol. 10, e1001289 (2012).
11. Huang, J., Kosal, M. The security impact of the neurosciences. Bulletin of the Atomic Scientists [online], http://thebulletin.org/security-impact-neurosciences (2008).
12. Farah, M. J. Neuroethics: the ethical, legal, and societal impact of neuroscience. Annu. Rev. Psychol. 63, 571-591 (2012).
13. Wheelis, M., Dando, M. Neurobiology: a case study of the imminent militarization of biology. Int. Rev. Red Cross 87, 553-571 (2005).
14. Dando, M. Advances in neuroscience and the biological and toxin weapons convention. Biotechnol. Res. Int. 2011, 973851 (2011).
15. The Chemical Weapons Convention and convergent trends in science and technology. The Royal Society [online], https://royalsociety.org/~/media/policy/projects/brain-waves/2013-08-04-chemical-weapons-convention-and-convergent-trends.pdf (2013).
16. Bray, R. M. et al. Department of Defense survey of health related behaviors among active duty military personnel. A component of the Defense Lifestyle Assessment Program (DLAP) Tricare [online], http://www.tricare.mil/tma/2008HealthBehaviors.pdf (2009).
17. Ryle, G. The Concept of Mind (Penguin Books, 2000).
18. Ehrenreich, B. Blood Rites: Origins and History of the Passions of War (Holt McDougall, 1998).
19. World armies still use psychoptropic drugs to make fearless machines of their soldiers. Pravda.ru [online], http://english.pravda.ru/world/europe/18-11-2008/106714-psychotropic-0/(2008).
20. Al-Husani, M., Goode, E. Prescription drug abuse rises among Iraqi troops, New York Times (New York) [online], http://www.nytimes.com/2008/12/21/world/middleeast/21drugs.html?pagewanted=all&-r=0 (20 Dec 2008).
21. Libya: Gaddafi forces accused of multiple war crimes. Telegraph (Lond.) [online] http://www.telegraph.co.uk/news/worldnews/africaandindianocean/libya/8730134/Libya-Gaddafi-forces-accused-of-multiple-war-crimes. html (30 Aug 2011).
22. Smith, D. Rebels accuse Gaddafi of using human shields as showdown in Sirte looms. Guardian (Lond.) [online], http://www.theguardian.com/world/2011/aug/31/rebels-accuse-gaddafi-human-shields (31 Aug 2011).
23. Oxford, E. Sleeping pill being used as courage drug by criminals: minister urged to tighten controls. Independent (Lond.) [online], http://www.independent. co.uk/news/uk/sleeping-pill-being-used-as-courage-drug-by-criminals-ministers-urged-to-tighten-controls-1399639.html (13 Jan 1994).
24. Robins, L. N. The Vietnam Drug User Returns; Final Report, September 1973. Hath Trust Digital Library [online], http://catalog.hathitrust.org/Record/000024389 (1974).
25. Giam, G. C. Effects of sleep deprivation with reference to military operations. Ann. Acad. Med. 26, 88-93 (1997).
26. Brown, C. A., Berry, R., Schmidt, A. Sleep and military members: emerging issues and nonpharmacological intervention. Sleep Disord. 160374, 1-6 (2013).
27. Caldwell, J. A., Caldwell, J. L. Fatigue in military aviation: an overview of US military-approved pharmacological countermeasures. Aviat. Space Environ. Med. 76, C39-C51 (2005).
28. The Academy of Medical Sciences. Brain science, addiction and drugs. The Academy of Medical Sciences [online], http://www.acmedsci.ac.uk/viewFile/524414fc8746a.pdf (2008).
29. Rose, S. P. 'Smart drugs': do they workAre they ethicalWill they be legalNature Rev. Neurosci. 3, 975-979 (2002).
30. Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E. E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-133 (1999).
31. Committee on Military Nutrition Research, Food and Nutrition Board. National Research Council. Committee on Military Nutrition Research: Activity Report 1992-1994. (National Academy Press, 1994).
32. Committee on Military Nutrition Research, Food and Nutrition Board. National Research Council. Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. (National Academy Press, 2001).
33. Newman, R. A., Kamimori, G. H., Wesensten, N. J., Picchioni, D., Balkin, T. J. Caffeine gum minimizes sleep inertia. Perceptual Motor Skills 116, 280-293 (2013).
34. Lieberman, H. R., Tharion, W. J., Shukitt-Hale, B., Speckman, K. L., Tulley, R. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land. Psychopharmacology 164, 250-261 (2002).
35. Gillingham, R. L., Keefe, A. A., Tikuisis, P. Acute caffeine intake before and after fatiguing exercise improves target shooting engagement time. Aviat. Space Environ. Med. 75, 865-871 (2004).
36. Batejat, D. et al. Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work. Aviat. Space Environ. Med. 77, 515-525 (2006).
37. Weiss, B., Laties, V. G. Enhancement of human performance by caffeine and the amphetamines. Pharmacol. Rev. 14, 1-36 (1962).
38. Strohl, M. P. Bradley's benzedrine studies on children with behavioral disorders. Yale J. Biol. Med. 84, 27-33 (2011).
39. Rasmussen, N. Medical science, the military: the Allies' use of amphetamine during World War II. J. Interdiscip. Hist. 42, 205-233 (2011).
40. Cocks, G. Psychotherapy in the Third Reich. 1st edn, Vol. 326 (Oxford Univ. Press, 1985).
41. Defalque, R. J., Wright, A. J. Methamphetamine for Hitler's Germany: 1937 to 1945. Bull. Anesth. Hist. 29, 21-24, 32 (2011).
42. Goodman, S. Thrills, spills and pills: Bond, Benzedrine and the pharmacology of peace. Med. Humanit. 36, 27-30 (2010).
43. Cornum, R., Caldwell, J. A., Cornum, K. Stimulant use in extended flight operations. Airpower J. 11, 53-58 (1997).
44. Sahakian, B., Morein-Zamir, S. Professor's little helper. Nature 450, 1157-1159 (2007).
45. Maher, B. Poll results: look who's doping. Nature 452, 674-675 (2008).
46. Desantis, A., Noar, S. M., Webb, E. M. Nonmedical ADHD stimulant use in fraternities. J. Stud. Alcohol Drugs 70, 952-954 (2009).
47. Minzenberg, M. J., Carter, C. S. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacol. 33, 1477-1502 (2008).
48. Repantis, D., Schlattmann, P., Laisney, O., Heuser, I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol. Res. 62, 187-206 (2010).
49. Whitmore, J. et al. United States Air Force Research Laboratory: the efficacy of modafinil as an operational fatigue countermeasure over several days of reduced sleep during a simulated escape and evasion scenario. Defense Technical Information Center [online], http://oai.dtic.mil/oai/oai?verb=getR ecord&metadataPrefix=html&identifier=A DA422857 (2004).
50. Whitmore, J. et al. United States Air Force Research Laboratory: a double-blind placebo-controlled investigation of the efficacy of modafinil for maintaining alertness and performance in sustained military ground operations. Defense Technical Information Center [online], http://www.dtic.mil/dtic/tr/fulltext/u2/a454558.pdf (2006).
51. Caldwell, J. A. et al. USAARL Report No. 99-17. The effects of Modafinil on aviator performance during 40 hours of continuous wakefulness: a UH-60 Helicopter Simulator Study. Defense Technical Information Center [online], http://www.dtic.mil/cgi-bin/GetTRDoc?AD=ADA365558 (1999).
52. Albuquerque, E. X., Santos, M. D., Alkondon, M., Pereira, E. F., Maelicke, A. Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 15 (Suppl. 1), 19-25 (2001).
53. Sahakian, B., Jones, G., Levy, R., Gray, J., Warburton, D. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry 154, 797-800 (1989).
54. Rogers, S. L. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil. Dement. Geriatr. Cogn. Disord. 9 (Suppl. 3), 29-42 (1998).
55. Mumenthaler, M. S. et al. Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacol. 28, 1366-1373 (2003).
56. Mumenthaler, M. S. et al. Nicotine deprivation and pilot performance during simulated flight. Aviat. Space Environ. Med. 81, 660-664 (2010).
57. Yesavage, J. A. et al. Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59, 123-125 (2002).
58. Yeghiayan, S. K., Georgelis, J. H., Maher, T. J., Lieberman, H. R. Beneficial effects of a protein free, high carbohydrate meal on rat coping behavior and neurotransmitter levels during heat stress. Nutr. Neurosci. 7, 335-340 (2004).
59. Lewis, M. D., Bailes, J. Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids. Milit. Med. 176, 1120-1127 (2011).
60. Aldington, D. Pain management in victims of conflict. Curr. Opin. Support. Palliat. Care 6, 172-176 (2012).
61. Wilker, S., Elbert, T., Kolassa, I. T. The downside of strong emotional memories: how human memory-related genes influence the risk for posttraumatic stress disorder-a selective review. Neurobiol. Learn. Mem.112, 75-86 (2013).
62. Maren, S. Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory. Neuron 70, 830-845 (2011).
63. Bouton, M. E., Bolles, R. C. Role of conditioned contextual stimuli in reinstatement of extinguished fear. Journal of experimental psychology. Animal Behav. Processes 5, 368-378 (1979).
64. Woud, M. L., Holmes, E. A., Postma, P., Dalgleish, T., Mackintosh, B. Ameliorating intrusive memories of distressing experiences using computerized reappraisal training. Emotion 12, 778-784 (2012).
65. Pearson, D. G., Deeprose, C., Wallace-Hadrill, S. M., Burnett Heyes, S., Holmes, E. A. Assessing mental imagery in clinical psychology: a review of imagery measures and a guiding framework. Clin. Psychol. Rev. 33, 1-23 (2013).
66. Nader, K., Schafe, G. E., Le Doux, J. E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406, 722-726 (2000).
67. Nader, K., Hardt, O. A single standard for memory: the case for reconsolidation. Nature Rev. Neurosci. 10, 224-234 (2009).
68. Parsons, R. G., Gafford, G. M., Baruch, D. E., Riedner, B. A., Helmstetter, F. J. Long-term stability of fear memory depends on the synthesis of protein but not mRNA in the amygdala. Eur. J. Neurosci. 23, 1853-1859 (2006).
69. Ledgerwood, L., Richardson, R., Cranney, J. d-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol. Psychiatry 57, 841-847 (2005).
70. Cahill, L., Prins, B., Weber, M., McGaugh, J. L. adrenergic activation and memory for emotional events. Nature 371, 702-704 (1994).
71. Pitman, R. K. et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry 51, 189-192 (2002).
72. Vaiva, G. et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol. Psychiatry 54, 947-949 (2003).
73. Stein, M. B., Kerridge, C., Dimsdale, J. E., Hoyt, D. B. Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients. J. Trauma. Stress 20, 923-932 (2007).
74. Davidson, J. R. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J. Clin. Psychiatry 67 (Suppl. 2), 34-39 (2006).
75. Oehen, P., Traber, R., Widmer, V., Schnyder, U. A randomized, controlled pilot study of MDMA (±3, 4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J. Psychopharmacol. 27, 40-52 (2013).
76. Blain, P. G. in Clinical Neurotoxicology: Syndromes, Substances, Environments. (ed. Dobbs, M.R) 660-673 (Saunders Elsevier, 2009).
77. Wax, P. M., Becker, C. E., Curry, S. C. Unexpected "gas" casualties in Moscow: a medical toxicology perspective. Ann. Emergency Med. 41, 700-705 (2003).
78. Riches, J. R., Read, R. W., Black, R. M., Cooper, N. J., Timperley, C. M. Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use. J. Anal. Toxicol. 36, 647-656 (2012).
79. Lakoski, J. M., Bosseau Murray, W., Kenny, J. The advantages and limitations of calmatives for use as a non-lethal technique. The Pennsylvania State University [online], https://www.erowid.org/psychoactives/war/war-article1.pdf (2000).
80. Saari, T. I., Uusi-Oukari, M., Ahonen, J., Olkkola, K. T. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol. Rev. 63, 243-267 (2011).
81. Kilpatrick, G. J. et al. CNS 7056: a novel ultra-short-acting Benzodiazepine. Anesthesiology 107, 60-66 (2007).
82. Berridge, C. W. Noradrenergic modulation of arousal. Brain Res. Rev. 58, 1-17 (2008).
83. Nelson, L. E. et al. The ?2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 98, 428-436 (2003).
84. Brown, E. N., Purdon, P. L., Van Dort, C. J. General anesthesia and altered states of arousal: a systems neuroscience analysis. Annu. Rev. Neurosci. 34, 601-628 (2011).
85. Zhang, Y. et al. Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China. J. Psychiatr. Res. 53, 99-102 (2014).
86. Feder, A. et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71, 681-688 (2014).
87. Daddona, P. E. Recent advances in peptide, protein and macromolecule drug delivery. Curr. Opin. Drug Discov. Devel. 2, 168-171 (1999).
88. Nathanson, V. The use of drugs as weapons: the concerns and responsibilities of heathcare professionals. British Medical Association (2007).
89. Davison, N. 'Non-lethal' Weapons (Palgrave Macmillan, 2009).
90. Pilkington, E. Judge approves use of 'truth serum' on accused Aurora shooter James Holmes. Guardian (Lond) [online], http://www.theguardian.com/world/2013/mar/12/judge-approves-truth-serum-james-holmes (12 Mar 2013).
91. Indian supreme court says 'truth drug' test is illegal. BBC News [online], http://news.bbc.co.uk/1/hi/8661408.stm (5 May 2010).
92. BBC Four. Pain, Pus and Poison: The Search for Modern Medicines (2013).
93. Dolen, G., Darvishzadeh, A., Huang, K. W., Malenka, R. C. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 501, 179-184 (2013).
94. Zak, P. J., Kurzban, R., Matzner, W. T. Oxytocin is associated with human trustworthiness. Hormones Behav. 48, 522-527 (2005).
95. Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., Fehr, E. Oxytocin increases trust in humans. Nature 435, 673-676 (2005).
96. Ellingsen, D. M. et al. In touch with your emotions: oxytocin and touch change social impressions while others' facial expressions can alter touch. Psychoneuroendocrinology 39, 11-20 (2014).
97. Tyls, F., Palenicek, T., Horacek, J. Psilocybin-summary of knowledge and new perspectives. Eur. Neuropsychopharmacol. 24, 342-356 (2014).
98. MacLean, K. A., Johnson, M. W., Griffiths, R. R. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J. Psychopharmacol. 25, 1453-1461 (2011).
99. Ministry of Defence. Global Strategic Trends-Out to 2040 4th edn [online], http://www.gov.uk/government/uploads/system/uploads/attachment-data/file/33717/GST4-v9-Feb10.pdf (Ministry of Defence, 2010).
100. BMA medical ethics committee. Boosting Your Brainpower: Ethical Aspects of Cognitive Enhancements (British Medical Association, 2007).
101. Human enhancement and the future of work. [online], http://www.acmedsci.ac.uk/viewFile/publicationDownloads/135228646747.pdf (The Royal Society, 2012).
102. Cohen Kadosh, R. Using transcranial electrical stimulation to enhance cognitive functions in the typical and atypical brain. Translat. Neurosci. 4, 20-33 (2013).
103. Luber, B., Lisanby, S. H. Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS). NeuroImage 85, Pt. 3, 961-970 (2014).
104. Maslen, H., Douglas, T., R. C., K., Savalescu, J. Mind Machines: the regulation of cognitive enhancement devices. Oxford Martin School [online], http://www. oxfordmartin.ox.ac.uk/downloads/briefings/Mind-Machines.pdf (2014).
105. Air Force Research Lab Wright-Patterson AFB OH Human Performance Wing (711th) Human Effectiveness Directorate/Biosciences And Performance Division [online], http://www.worldcat.org/identities/nc-air%20force%20research%20lab%20 wright%20patterson%20afb%20oh%20human%20 performance%20wing%20711th%20human%20 effectiveness%20directorate%20biosciences%20 and%20performance%20division/(2009).
106. Equipment, Support, and Technology for UK Defence and Security: A Consultation Paper [online], http://www.gov.uk/government/uploads/system/uploads/attachment-data/file/35916/cm7989-Eqpt-supp-tech-ukdef.pdf (Crown, 2010).
107. Advances in Bioscience for Airmen Performance, Solicitation number BAA-09-02-R. Federal Business Opportunities [online], http://www.fbo.gov/?s=opport unity&mode=form&id=9af277f06242b8c5cc9fef68 cabd8e93&tab=core&-cview=1 (2009).
108. Brunelin, J., Levasseur-Moreau, J., Fecteau, S. Is it ethical and safe to use non-invasive brain stimulation as a cognitive and motor enhancer device for military servicesA reply to Sehm and Ragert. Front. Hum. Neurosci. 7, 874 (2013).
109. Levasseur-Moreau, J., Brunelin, J., Fecteau, S. Non-invasive brain stimulation can induce paradoxical facilitation. Are these neuroenhancements transferable and meaningful to security services, Front. Hum. Neurosci. 7, 449 (2013).
110. Sehm, B., Ragert, P. Why non-invasive brain stimulation should not be used in military and security services. Front. Hum. Neurosci. 7, 553 (2013).
111. Neuroscience: brain buzz. Nature 472, 156-159 (2011).
112. Kincses, T. Z., Antal, A., Nitsche, M. A., Bartfai, O., Paulus, W. Facilitation of probabilistic classification learning by transcranial direct current stimulation of the prefrontal cortex in the human. Neuropsychologia 42, 113-117 (2004).
113. Clark, V. P. et al. TDCS guided using fMRI significantly accelerates learning to identify concealed objects. NeuroImage 59, 117-128 (2012).
114. Bassett, D. S. et al. Dynamic reconfiguration of human brain networks during learning. Proc. Natl Acad. Sci. USA 108, 7641-7646 (2011).
115. Wu, G., Gonzalez, R. Common consequence conditions in decision-making under risk. J. Risk Uncertainty 16, 115-139 (1998).
116. Manes, F. et al. Decision-making processes following damage to the prefrontal cortex. Brain 125, 624-639 (2002).
117. Clark, L., Manes, F., Antoun, N., Sahakian, B. J., Robbins, T. W. The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage. Neuropsychologia 41, 1474-1483 (2003).
118. Rushworth, M. F., Behrens, T. E. Choice, uncertainty and value in prefrontal and cingulate cortex. Nature Neurosci. 11, 389-397 (2008).
119. Tobler, P. N., Christopoulos, G. I., O'Doherty, J. P., Dolan, R. J., Schultz, W. Risk-dependent reward value signal in human prefrontal cortex. Proc. Natl Acad. Sci. USA 106, 7185-7190 (2009).
120. Deeny, S., Hillman, C., Janelle, C., Hatfield, B. D. Cortico-cortical communication and superior performance in skilled marksmen: An EEG coherence analysis. J. Sport Exercise Psychol. 25, 188-204 (2003).
121. Hatfield, B. D., Haufler, A. J., Hung, T. M., Spalding, T. W. Electroencephalographic studies of skilled psychomotor performance. J. Clin. Neurophysiol. 21, 144-156 (2004).
122. deCharms, R. C. et al. Control over brain activation and pain learned by using real-time functional MRI. Proc. Natl Acad. Sci. USA 102, 18626-18631 (2005).
123. Jensen, M. P., Day, M. A., Miro, J. Neuromodulatory treatments for chronic pain: efficacy and mechanisms. Nature Rev. Neurol. 10, 167-178 (2014).
124. Cowings, P. S., Kellar, M. A., Folen, R. A., Toscano, W. B., Burge, J. D. Autogenic feedback training exercise and pilot performance: enhanced functioning under search-and-rescue flying conditions. Int. J. Avi. Psychol. 11, 303-315 (2001).
125. Landers, D. M. et al. The influence of electrocortical biofeedback on performance in pre-elite archers. Med. Sci. Sports Exercise 23, 123-129 (1991).
126. Kerick, S. E., Douglass, L. W., Hatfield, B. D. Cerebral cortical adaptations associated with visuomotor practice. Med. Sci. Sports Exercise 36, 118-129 (2004).
127. Arns, M., Kleinnijenhuis, M., Fallahpour, K., Breteler, R. Golf performance enhancement and real-life neurofeedback training using personalized event-locked EEG profiles. J. Neurother. 11, 11-18 (2009).
128. Gentili, R. J. Non-invasive functional brain biomarkers for cognitive-motor performance assessment: towards new brain monitoring applications. Hum. Computer Interaction 20, 159-168 (2011).
129. Gentili, R. J., Bradberry, T. J., Oh, H., Hatfield, B. D., Contreras-Vidal, J. L. Cerebral cortical dynamics during visuomotor transformation: adaptation to a cognitive-motor executive challenge. Psychophysiology 48, 813-824 (2011).
130. Miller, M. et al. EEG assessment of incremental changes in cognitive workload during an ecologically valid visuomotor task. Abstract number: 601.8/KKK7. 2010 Neuroscience Meeting Planner (2009).
131. Smith, M. E., Gevins, A., Brown, H., Karnik, A., Du, R. Monitoring task loading with multivariate EEG measures during complex forms of human-computer interaction. Hum. Factors 43, 366-380 (2001).
132. Nishimoto, S. et al. Reconstructing visual experiences from brain activity evoked by natural movies. Curr. Biol. 21, 1641-1646 (2011).
133. Haxby, J. V. Multivariate pattern analysis of fMRI: the early beginnings. NeuroImage 62, 852-855 (2012).
134. Hatsopoulos, N. G., Donoghue, J. P. The science of neural interface systems. Annu. Rev. Neurosci. 32, 249-266 (2009).
135. Simeral, J. D., Kim, S. P., Black, M. J., Donoghue, J. P., Hochberg, L. R. Neural control of cursor trajectory and click by a human with tetraplegia 1000 days after implant of an intracortical microelectrode array. J. Neural Eng. 8, 025027 (2011).
136. White, S. Brave new world: neurowarfare and the limits of international humanitarian law. Cornell Inter. Law J. 41, 177-210 (2003).
137. Silence of the neuroengineers. Nature 423, 787 (2003).
138. Hoag, H. Remote control. Nature 423, 796-798 (2003).
139. Rizzuto, D. S., Breznen, B., Greger, B. Military-funded research is not unethical. Nature 424, 369 (2003).
140. Wolpert, L. Is science dangerousNature 398, 281-282 (1999).
141. US Department of Justice. The United States Department of Justice Amerithrax Investigative Summary. US Department of Justice [online], http://www.justice.gov/archive/amerithrax/docs/amx-investigative-summary2.pdf (2010).
142. Rose, S. A. Faustian bargainEMBO Rep. 12, 1086 (2011).
143. Dando, M., Rappert, B. (eds) Codes of Conduct for the Life Sciences: Some Insights from UK Academia. Briefing Paper no. 16. University of Bradford [online], http://www.brad.ac.uk/acad/sbtwc/briefing/BP-16-2ndseries.pdf (2005).
144. USADA Media Relations. Statement From USADA CEO Travis T. Tygart Regarding The U.S. Postal Service Pro Cycling Team Doping Conspiracy. US Anti-Doping Agency [online], http://cyclinginvestigation.usada.org (2012).
145. Sparling, P. B. The Lance Armstrong saga: a wake-up call for drug reform in sports. Curr. Sports Med. Rep. 12, 53-54 (2013).
146. Chatterjee, A. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology 63, 968-974 (2004).
147. Baranski, J. V., Pigeau, R. A. Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. J. Sleep Res. 6, 84-91 (1997).
148. Johnson, K. Army seeking death penalty in massacre of 16 Afghans. New York Times (New York) [online], http://www.nytimes.com/2012/12/20/us/robert-bales-faces-death-penalty-in-afghan-massacre.html?-r=0 (19 Dec 2012).
149. Buchanan, M. Drugs involved in friendly fire deaths. BBC News [online], http://news.bbc.co.uk/1/hi/world/americas/2595641.stm (20 Dec 2002).
150. Henry, M., Fishman, J. R., Youngner, S. J. Propranolol and the prevention of post-traumatic stress disorder: is it wrong to erase the "sting" of bad memoriesAm. J. Bioeth. 7, 12-20 (2007).
151. Foote, S. B. in Managing the Medical Arms Race: Innovation and Public Policy in the Medical Device Industry (Univ. of California, 1992).
152. Gable, R. S. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 99, 686-696 (2004).